Medicine and Dentistry
Age
6%
Analysis
11%
Assessment
6%
B Cell
5%
Central Nervous System
8%
Cohort Analysis
18%
Cyclophosphamide Plus Doxorubicin Plus Prednisolone Plus Rituximab Plus Vincristine
6%
Diagnosis
13%
Diffuse Large B-Cell Lymphoma
50%
Diseases
13%
Fluorodeoxyglucose F 18
6%
Follicular Lymphoma
8%
Follow up
13%
Gene
9%
Hazard Ratio
7%
Hematological Cancer
9%
Hodgkin's Lymphoma
15%
Inpatient
22%
International Prognostic Index
9%
Lymphoma
40%
Malignant Neoplasm
5%
Neoplasm
11%
Non-Hodgkin Lymphoma
11%
Overall Survival
10%
Patient
100%
Peripheral T-Cell Lymphoma
5%
Personalized Medicine
9%
PET-CT
20%
Positron Emission Tomography
5%
Prognosis
7%
Prophylaxis
5%
Spontaneous Remission
11%
Therapeutic Procedure
51%